Xcout Intel
Syneos Health
Syneos Health is a biopharmaceutical solutions organization and contract research organization (CRO) that provides clinical development, regulatory, safety, and commercialization services. It serves biopharmaceutical and life sciences companies by offering clinical trials, consulting, marketing, and deployment solutions to help bring therapies to market.
Subscribe to see Syneos Health’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Syneos Health at a glance
Syneos Health is a pharmaceuticals company headquartered in United States. Xcout tracks 9 named people at Syneos Health, including Costa Panagos (Chief Executive Officer). Xcout recorded 1 job posting from Syneos Health in the last 90 days.
Syneos Health leadership
- Costa PanagosChief Executive Officer
- Michael BrooksChief Operating Officer
- Michael BonelloChief Financial Officer
- Dr. Greg LicholaiChief Medical Officer
- Mike MontelloChief Digital and Information Officer
- Simon BartleChief Human Resources Officer
3 more named people on record for Syneos Health, with roles, board committees and tenure — see the full roster →
Hiring at Syneos Health
Xcout recorded 1 job posting from Syneos Health in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Syneos Health's hiring signals →
Syneos Health competitors
A few of Syneos Health's closest competitors — see the full list of competitors and alternatives →
Parexel is a contract research organization (CRO) that provides comprehensive biopharmaceutical services to the life sciences industry. The company offers end-to-end solutions spanning portfolio optimization, regulatory strategy, Phase I-IV clinical trials, market access planning, and post-approval lifecycle management.
ICON plc is a clinical research organization (CRO) that provides outsourced clinical, consulting, and commercial services to pharmaceutical, biotechnology, medical device, and government organizations. The company assists clients with drug development, clinical trials, laboratory services, regulatory affairs, and market access strategies.
PPD is a global contract research organization (CRO) providing comprehensive clinical development, laboratory, and functional service partnership solutions for the pharmaceutical and biotech industries.
Clinigen is a global pharmaceutical services company that helps healthcare providers and pharmaceutical companies access, supply, and distribute medicines, including unlicensed and specialty medicines. It also supports clinical-trial supply and post-approval commercialization of pharmaceutical products.
Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's operations are divided into two main segments: Clinical Services and Enabling Services. Its Clinical Services division offers support across the entire spectrum of clinical pharmacology and development. The Enabling Services segment, conversely, delivers patient access programs and cutting-edge clinical trial technology solutions, aiming to simplify complex randomization processes and optimize the supply of trial medications for its customers. Fortrea presents a range of engagement options, such as full-service provision, functional service provider (FSP) models, and hybrid structures. Additionally, its portfolio includes managing clinical trials from Phase I through IV, offering distinctive technology-powered trial solutions, and providing post-market approval services. The company's client base primarily consists of pharmaceutical, biotechnology, and medical device entities. Fortrea Holdings Inc. was founded in 2023 and has its headquarters in Durham, North Carolina.
Shanghai Medicilon Inc. is a contract research organization (CRO) that provides comprehensive drug discovery, chemistry, biology, CMC development, and preclinical research services. The company serves pharmaceutical and biotechnology innovators by offering integrated solutions spanning chemical synthesis, pharmacology, ADME/DMPK, and safety assessment to advance drug candidates toward IND filings.
Get Syneos Health's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Syneos Health? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Syneos Health in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access